Solupharm Limited

Pre-clinical MS Research using EAE models

Pre-clinical MS research using EAE systems

Solupharm Limited UK was established by Director, Dr Chris Bolton, in 1999 and offers the unique combination of academic expertise coupled with an appreciation of the pharmaceutical industry’s requirements for the evaluation of potential multiple sclerosis (MS) therapies through the dedicated use of experimental autoimmune encephalomyelitis (EAE) models.

Solupharm operates from laboratory and biological service facilities in Bristol, UK and is one of the most comprehensive contract research companies available for pre-clinical MS research offering an unprecedented range of EAE systems.